These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30487137)

  • 21. Diagnostic accuracy of low-dose dual-input computed tomography perfusion in the differential diagnosis of pulmonary benign and malignant ground-glass nodules.
    Hu X; Gou J; Wang L; Lin W; Li W; Yang F
    Sci Rep; 2024 Jul; 14(1):17098. PubMed ID: 39048627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
    Seder CW; Kubasiak JC; Pithadia R; Basu S; Fhied C; Tarhoni I; Davila E; Alnajjar H; Chmielewski GW; Warren WH; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2015 Aug; 100(2):429-36. PubMed ID: 26138771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.
    Hanas JS; Peyton MD; Lerner MR; Lightfoot SA; Deb SJ; Hanas RJ; Vu NT; Kupiec TC; Stowell DE; Brackett DJ; Dubinett SM; Hocker JR
    Cancer Invest; 2014 May; 32(4):136-43. PubMed ID: 24579933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules.
    Lastwika KJ; Kargl J; Zhang Y; Zhu X; Lo E; Shelley D; Ladd JJ; Wu W; Kinahan P; Pipavath SNJ; Randolph TW; Shipley M; Lampe PD; Houghton AM
    Am J Respir Crit Care Med; 2019 May; 199(10):1257-1266. PubMed ID: 30422669
    [No Abstract]   [Full Text] [Related]  

  • 25. Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules.
    Tu M; Wang X; Liu H; Jia H; Wang Y; Li J; Zhang G
    Sci Rep; 2024 Sep; 14(1):22532. PubMed ID: 39341939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid.
    Kahn N; Meister M; Eberhardt R; Muley T; Schnabel PA; Bender C; Johannes M; Keitel D; Sültmann H; Herth FJ; Kuner R
    J Thorac Oncol; 2012 Jun; 7(6):1001-8. PubMed ID: 22588153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
    J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
    Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
    Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
    [No Abstract]   [Full Text] [Related]  

  • 29. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
    Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
    Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
    Xiao F; Yu Q; Zhang Z; Liu D; Liang C
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
    Kubasiak JC; Seder CW; Pithadia R; Basu S; Fhied C; Phillips WW; Daly S; Shersher DD; Yoder MA; Chmielewski G; Edell ES; Maldonado F; Liptay MJ; Borgia JA
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):727-34.e1-3; discussion 734. PubMed ID: 25312225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic categorization of lung nodules: Radiomic descriptors of CT attenuation distribution patterns of solid and subsolid nodules in low-dose CT.
    Zhou C; Chan HP; Chughtai A; Hadjiiski LM; Kazerooni EA; Wei J
    Eur J Radiol; 2020 Aug; 129():109106. PubMed ID: 32526671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
    Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
    Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive diagnosis of pulmonary nodules using a circulating tsRNA-based nomogram.
    Wang Q; Song X; Zhao F; Chen Q; Xia W; Dong G; Xu L; Mao Q; Jiang F
    Cancer Sci; 2023 Dec; 114(12):4607-4621. PubMed ID: 37770420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
    Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasculature surrounding a nodule: A novel lung cancer biomarker.
    Wang X; Leader JK; Wang R; Wilson D; Herman J; Yuan JM; Pu J
    Lung Cancer; 2017 Dec; 114():38-43. PubMed ID: 29173763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative CT analysis of lung parenchyma to improve malignancy risk estimation in incidental pulmonary nodules.
    Peters AA; Weinheimer O; von Stackelberg O; Kroschke J; Piskorski L; Debic M; Schlamp K; Welzel L; Pohl M; Christe A; Ebner L; Kauczor HU; Heußel CP; Wielpütz MO
    Eur Radiol; 2023 Jun; 33(6):3908-3917. PubMed ID: 36538071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.